Trachoma trial: stopping antibiotics may be safe in Low-Risk areas
NCT ID NCT04185402
First seen Mar 30, 2026 · Last updated May 15, 2026 · Updated 10 times
Summary
This study looked at whether communities with low levels of trachoma (an eye infection that can cause blindness) can safely stop yearly antibiotic treatment. Over 3,900 people in Niger took part. Some communities stopped the annual azithromycin, while others continued for three more years. The goal was to see if stopping would cause the infection to return.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRACHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Programme National de Santé Oculaire (PNSO)
Niamey, Niger
Conditions
Explore the condition pages connected to this study.